Adenosine is a known promoter of tumor proliferation and angiogenesis, and in the case of GBM, it has been implicated in the development of TMZ chemoresistance and CD8+ T cell dysfunction via the A2B adenosine receptor (Takenaka et al., 2019; Yan et al., 2019). The gene discussed is CD8A; the disease is glioblastoma.